Kalvotech
kalvotech.com
Actively hiring
Biomaterials
Advanced Materials
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Aug 2026 · 1 mo ago
Grants
$531k
2 grants · CORDIS
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 31
Raised a round Venture round
Apr 30
Raised a round Venture round
Jan 5
Raised a round Venture round
Aug 1, 2025
Won a grant $222k · CORDIS
Jul 25, 2025
Raised a round Venture round
Feb 1, 2024
Won a grant $309k · CORDIS
Jan 29, 2024
Raised a round Venture round
Jan 10, 2023
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Aug 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Apr 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Jan 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Aug 2025 | $222k | — | CORDIS |
| Venture round | Jul 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Feb 2024 | $309k | — | CORDIS |
| Venture round | Jan 2024 | — | — | find-and-update.company-information.service.gov.uk |
Registers and programsofficial lists and records that name the company
| Legal entity | KALVOTECH LIMITED | Companies House |
| Registered | 10 Jan 2023 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Sustanix develops novel biomolecules for advanced biomaterials, takes it from lab to industrial scale.
MYCOTEX® is a Biomaterial Technology Company. We engineer next-generation biomaterials for real world products.
司由知名留美科学家舒晓正博士于2008年4月28日成立，是一家以自交联和生物模拟材料(Advanced Self-Crosslinked & Biomimetic Biomaterials)为技术平台，深耕临床医学和生物医药领域，具备自主研发能力的高新技术企业。致力于成为国内外新…
AI SILK develops sustainable silk-like biomaterials by combining biotechnology and computational design. It engineers recombinant silk…
TômTex is a materials innovation company that is creating a new class of next-gen biomaterials.
A climate technology company reducing global plastic dependency by scaling biomaterial adoption.
Financials
Total raised
$531k
Latest round
Venture - Series Unknown
Funding rounds
7